Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Why tumour markers are not recommended as screening tests

Share :

Choosing Wisely Cambodia 2023

18 Mar 2023
Published: 20 Apr 2023
Views: 297
Rating:
Save
Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines

Dr Frederic Ting speaks to ecancer about his talk on the ‘why tumour markers are not recommended as screening tests’ at the "Choosing Wisely Cambodia 2023” congress, held in Phnom Penh on the 18th March 2023.



He highlights that tumour markers are not as effective as screening tools because of its low diagnostic sensitivity and low specificity.

Related Videos

The 5-year long-term outcomes of radiation technique for locally advanced NSCLC
Dr Stephen Chun - MD Anderson, Houston, USA
The 5-year long-term outcomes of radiation technique for locally advanced NSCLC ( Dr Stephen Chun - MD Anderson, Houston, USA )
14 Sep 2023
Choosing Wisely in radiology Tanzania
Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania
Choosing Wisely in radiology Tanzania ( Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )
18 May 2023
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast...
Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German )
2 May 2023
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small...
Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany )
2 May 2023
The use of IORT at Universitätsmedizin Mannheim hospital
Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany
The use of IORT at Universitätsmedizin Mannheim hospital ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany )
2 May 2023
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant...
Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )
25 Apr 2023
War in Ukraine: The logistical challenges of transferring medical materials
Dr Horia Vulpe, Dr Ruslan Baltaga
War in Ukraine: The logistical challenges of transferring medical materials ( Dr Horia Vulpe, Dr Ruslan Baltaga )
3 Apr 2023
Choosing Wisely to mitigate financial toxicity in cancer care in Africa
Dr Penina Mnandi - Ocean Road Cancer Institute, Dar es Salaam, Tanzania
Choosing Wisely to mitigate financial toxicity in cancer care in Africa ( Dr Penina Mnandi - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )
22 Mar 2023
Advancing breast cancer diagnosis in the developing world
Dr Hans Junkermann, Prof Dr.Erkin Arıbal and Dr Richard Rainsbury
Advancing breast cancer diagnosis in the developing world ( Dr Hans Junkermann, Prof Dr.Erkin Arıbal and Dr Richard Rainsbury )
21 Mar 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation